Key facts
- Lawrence Steinman filed SCHEDULE 13D/A for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
- Disclosed ownership: 3.1%.
- Date of event: 01 Mar 2025.
Lawrence Steinman - 01 Mar 2025 SCHEDULE 13D/A Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)
- Filing Manager
- Lawrence Steinman
- Reporting Manager
- Lawrence Steinman
- Symbol
- KTTA
- Shares outstanding
- 2,705,097 shares
- Disclosed Ownership
- 83,858 shares
- Ownership
- 3.1%
- Form type
- SCHEDULE 13D/A
- Filing time
- 06 Mar 2025, 21:55:13 UTC
- Date of event
- 01 Mar 2025
- SEC
- View on sec.gov
Key filing fact
Lawrence Steinman disclosed 3.1% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 01 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Mar 2025, 21:55.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lawrence Steinman | 3.1% | 83,858 | 83,858 | 0 | /s/ Lawrence Steinman | Lawrence Steinman | 0001132679 |
CIK / CUSIP context first